TETRAULT LYNN A. 4
4 · NEOGENOMICS INC · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Neogenomics (NEO) Director Lynn A. Tetrault Sells 5,307 Shares
What Happened Lynn A. Tetrault, a director of Neogenomics, reported the sale of 5,307 shares of Neogenomics common stock on June 15, 2026. The shares were sold in an open-market/private sale at $11.10 per share for a total sale value of $58,908. This was a sale (not a purchase) and is typically considered a routine insider disposition rather than an affirmative bullish purchase.
Key Details
- Transaction date: June 15, 2026
- Transaction type: Open market/private sale (Code S)
- Price per share: $11.10; Shares sold: 5,307; Total proceeds: $58,908
- Shares owned after transaction: Not specified in the provided filing details
- Footnote: F1 — once vested, the shares of common stock are not subject to expiration
- Filing: Form 4 filed June 17, 2026 (filed within the standard two-business-day reporting window)
Context Sales by directors can be for many personal or portfolio reasons and do not by themselves indicate a change in company prospects. The filing’s footnote notes these were vested shares that aren't subject to expiration; no indication was given of an option exercise, 10b5-1 plan, or gift in the provided details.
Insider Transaction Report
- Sale
Common Stock
2026-06-15$11.10/sh−5,307$58,908→ 86,115 total
- 7,000(indirect: By IRA)
Common Stock
- 2,136
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (2,136 underlying) - 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 972
Stock Option (Right to Buy)
Exercise: $41.76From: 2022-10-11Exp: 2028-10-11→ Common Stock (972 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 16,107
Stock Option (Right to Buy)
Exercise: $7.28From: 2026-06-01Exp: 2035-06-01→ Common Stock (16,107 underlying) - 11,069
Stock Option (Right to Buy)
Exercise: $10.52From: 2027-06-01Exp: 2036-06-01→ Common Stock (11,069 underlying) - 15,970
Restricted Stock Unit
[F1]Exercise: $0.00From: 2027-06-01→ Common Stock (15,970 underlying)
Footnotes (1)
- [F1]Once vested, the shares of common stock are not subject to expiration.